155 related articles for article (PubMed ID: 34103913)
1. Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer.
Cao J; Huang J; Gui S; Chu X
Int J Nanomedicine; 2021; 16():3725-3739. PubMed ID: 34103913
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of phytantriol liquid crystal as a liquid embolic agent.
Fang X; Shen A
Pharm Dev Technol; 2020 Jun; 25(5):610-616. PubMed ID: 32008407
[TBL] [Abstract][Full Text] [Related]
3. Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent.
Qin L; Mei L; Shan Z; Huang Y; Pan X; Li G; Gu Y; Wu C
Drug Dev Ind Pharm; 2016; 42(2):307-16. PubMed ID: 26035332
[TBL] [Abstract][Full Text] [Related]
4. Dual drug-loaded cubic liquid crystal gels for transdermal delivery: inner structure and percutaneous mechanism evaluations.
Chu X; Wang X; Tian C; Liu L; Xia M; Jiang J; Gui S
Drug Dev Ind Pharm; 2019 Dec; 45(12):1879-1888. PubMed ID: 31672067
[TBL] [Abstract][Full Text] [Related]
5. In situ hexagonal liquid crystal for intra-articular delivery of sinomenine hydrochloride.
Liang X; Chen Y; Wu L; Maharjan A; Regmi B; Zhang J; Gui S
Biomed Pharmacother; 2019 Sep; 117():108993. PubMed ID: 31228805
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.
Ning Q; Liu YF; Ye PJ; Gao P; Li ZP; Tang SY; He DX; Tang SS; Wei H; Yu CY
ACS Appl Mater Interfaces; 2019 Mar; 11(11):10578-10588. PubMed ID: 30802029
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and evaluation of intra-articular injectable sinomenine hydrochloride-loaded in situ liquid crystals].
Chen YL; Gui SY; Liang X; Wang SM; Jiang XJ
Yao Xue Xue Bao; 2016 Jan; 51(1):132-9. PubMed ID: 27405175
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition.
Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK
Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911
[TBL] [Abstract][Full Text] [Related]
10. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
[TBL] [Abstract][Full Text] [Related]
11. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
Ni W; Li Z; Liu Z; Ji Y; Wu L; Sun S; Jian X; Gao X
J Pharm Sci; 2019 Mar; 108(3):1284-1295. PubMed ID: 30395829
[TBL] [Abstract][Full Text] [Related]
12. Functionalized PAMAM-based Nanoformulation for Targeted Delivery of 5-Fluorouracil in Hepatocellular Carcinoma.
Chen S; Ouyang H; He D; Liu D; Wang X; Chen H; Pan W; Li Q; Xie W; Yu C
Curr Pharm Des; 2022; 28(25):2113-2125. PubMed ID: 35524673
[TBL] [Abstract][Full Text] [Related]
13. A Natural Membrane Vesicle Exosome-based Sinomenine Delivery Platform for Hepatic Carcinoma Therapy.
Wang Y; Zhao L; Yuan W; Liang L; Li M; Yu X; Wang Y
Curr Top Med Chem; 2021 Oct; 21(14):1224-1234. PubMed ID: 34126903
[TBL] [Abstract][Full Text] [Related]
14. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
[TBL] [Abstract][Full Text] [Related]
15. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma.
Varshosaz J; Fard MM; Mirian M; Hassanzadeh F
Anticancer Agents Med Chem; 2020; 20(3):346-358. PubMed ID: 31566137
[TBL] [Abstract][Full Text] [Related]
16. A Novel Phytantriol-Based In Situ Liquid Crystal Gel for Vaginal Delivery.
Jie H; Liu L; Shuangying G; Xingqi W; Rongfeng H; Yong Z; Chunling T; Mengqiu X; Xiaoqin C
AAPS PharmSciTech; 2019 May; 20(5):185. PubMed ID: 31062112
[TBL] [Abstract][Full Text] [Related]
17. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
[TBL] [Abstract][Full Text] [Related]
18. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
Huang C; Li NM; Gao P; Yang S; Ning Q; Huang W; Li ZP; Ye PJ; Xiang L; He DX; Tan XW; Yu CY
Drug Deliv; 2017 Nov; 24(1):459-466. PubMed ID: 28219253
[TBL] [Abstract][Full Text] [Related]
20. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
